We use cookies for a better user experience. Read our Privacy Policy
I Agree
Drug and Gene Delivery Systems Market
The segments in the global drug and gene delivery systems market based on the system of delivery consist of drug delivery systems (such as prodrug implants, targeted drug delivery, intrauterine implants, and polymeric drug delivery) and gene delivery systems (such as non-viral gene delivery as well as viral gene delivery systems). The viral gene delivery systems segment can be further classified into sub-sections such as lentivirus vector, adeno-associated virus vector, herpes simplex virus vector, adenovirus vector, retrovirus vector, and Sendai virus vector, among others. Moreover, the non-viral gene delivery system segment is further divided into physical methods, natural organic compounds, and chemical methods.
The increasing prevalence of chronic diseases including diabetes and cancer is influencing the demand within the global drug and gene delivery systems market in coming years. Furthermore, the rising prevalence of cardiovascular diseases around the world is also supplementing the development trajectory of the global drug and gene delivery systems market. The segments in the global drug and gene delivery systems market based on the route of administration are injectable, transdermal, nasal, oral, inhalation, ocular, and topical. Some of the leading application segments for the products and solutions within the global drug and gene delivery systems market include oncology, urology, CNS, infectious diseases, ophthalmology, and diabetes, among others.
Major geographical regions and leading nations functional within the global drug and gene delivery systems market include Europe (including the United Kingdom, France, Germany, Italy, Spain, and rest of the Europe), North America (including Canada and the United States), Asia Pacific (including China, Australia, India, Japan, New Zealand, and rest of the Asia Pacific), Middle East and Africa (including South Africa, the Gulf Cooperation Council countries, Israel, and rest of the Middle East and Africa), and Latin America (including Mexico, Brazil, and rest of the Latin America).
Regionally, North America accounted for the largest share in the global drug and gene delivery systems market in recent past, owing to rising prevalence of various chronic diseases in the United States. Furthermore, another region expected to perform admirably within the global drug and gene delivery systems market in the next few years is Asia Pacific. The development of the global drug and gene delivery systems market in Asia Pacific can be attributed to rising prevalence of HIV and cancer in the regional economies. Furthermore, high prevalence of HIV in Saudi Arabia and South Africa is expected to lead the global drug and gene delivery systems market in Middle East and Africa in near future.
Few of the leading incumbent players and manufacturers operational within the global drug and gene delivery systems market include Pfizer, Inc., AstraZeneca PLC, SiBiono GeneTech Co., Human Stem Cells Institute, Johnson & Johnson, Becton, Dickinson and Company, Oxford BioMedica, Amgen Inc., Bayer AG, Shanghai Sunway Biotech Co., Ltd., F. Hoffmann La Roche Ltd., and Novartis AG, among others. Players in the global drug and gene delivery systems market are focused on adopting new and advanced drug development and gene delivery systems in order to diversify their product portfolios.
For example, Becton, Dickinson, and Company launched a new circulating cell free DNA collection tube called PAXgene, intended for prenatal cancer testing in February of 2018. Similarly, Novartis Access was launched by the Novartis AG in Kenya in October of 2015 with an aim to provide the countrymen with their portfolio of 15 affordable drugs, aimed at treating diabetes, breast cancer, respiratory disorders, and cardiovascular disorders.
The drug and gene delivery systems market has been segmented as follows:
|
Delivery System |
|
|
Route of Administration |
|
|
Application |
|
|
Geography |
|
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
Drug and gene delivery systems market will expand at a promising CAGR of over 6% between 2017 and 2025
Drug and gene delivery systems market is driven by increasing prevalence of chronic diseases including diabetes and cancer is influencing the demand
North America accounted for the largest share in the global drug and gene delivery systems market in recent past, owing to rising prevalence of various chronic diseases
The targeted drug delivery segment is expected to account for the dominant share in the drug and gene delivery systems market over the report’s forecast period
Key players in the global drug and gene delivery systems market include Boston Scientific Corporation, Epeius Biotechnologies Corporation, Human Stem Cells Institute, Boston Scientific Corporation, Baxter International, Inc., and AstraZeneca plc.
Section 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Section 2 Assumptions and Research Methodology
Section 3 Executive Summary
Section 4 Market Overview
4.1. Product Definitions
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3 Opportunities
4.4. Global Drug and Gene Delivery System Market Forecast
4.5. Porter's Five Forces Analysis
4.6. Global Drug and Gene Delivery System Market Outlook
4.7. Technological Advancements in Drug and Gene Delivery Products
4.8. Regulatory Scenario
4.9. Key Mergers & Acquisitions
4.10. Drug and Gene Therapy Pipeline
Section 5 Global Drug and Gene Delivery Systems Market Analysis, by Delivery System
5.1. Key Findings / Developments
5.2. Introduction: Drug Delivery Systems
5.3. Introduction: Gene Delivery Systems
5.4. Introduction & Definitions
5.5. Global Drug and Gene Delivery Systems Market Value Share Analysis, by Drug Delivery System
5.6. Global Drug and Gene Delivery Systems Market Value Share Analysis, by Gene Delivery System
5.7. Global Drug and Gene Delivery Systems Market Forecast, by Drug Delivery System
5.7.1. Intrauterine Implants
5.7.2. Prodrug Implants
5.7.3. Polymeric Drug Delivery
5.7.4. Targeted Drug Delivery
5.8. Global Drug and Gene Delivery Systems Market Forecast, by Gene Delivery System
5.8.1. Viral Gene Delivery
5.8.2. Non-viral Gene Delivery
5.8.3. Combined Hybrid Systems
5.9. Global Drug and Gene Delivery Systems Market Forecast, by Gene Delivery System: Viral Gene Delivery
5.9.1. Adenovirus Vector
5.9.2. Lentivirus Vector
5.9.3. Retrovirus Vector
5.9.4. Adeno-associated Virus Vector
5.9.5. Sendai Virus Vector
5.9.6. Herpes Simplex Virus Vector
5.9.7. Others
5.10. Global Drug and Gene Delivery Systems Market Forecast, by Gene Delivery System: Non-viral Gene Delivery
5.10.1. Natural Organic Compounds
5.10.2. Physical Methods
5.10.3. Chemical Methods
5.11. Global Drug and Gene Delivery Systems Market Analysis, by Drug Delivery System
5.12. Global Drug and Gene Delivery Systems Market Analysis, by Gene Delivery System
5.13. Global Drug and Gene Delivery Systems Market Analysis, by Gene Delivery System: Viral Gene Delivery
5.14. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Drug Delivery System
5.15. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Gene Delivery System
Section 06 Global Drug and Gene Delivery System Market Analysis, by Application
6.1. Key Findings / Developments
6.2. Introduction & Definitions
6.3. Introduction: Drug Delivery Systems
6.4. Introduction: Gene Delivery Systems
6.5. Global Drug Delivery System Market Value Share Analysis, by Application
6.6. Global Gene Delivery System Market Value Share Analysis, by Application
6.7. Global Drug Delivery System Market Forecast, by Application
6.8.1. Infectious Diseases
6.8.2. Oncology
6.8.3. Ophthalmology
6.8.4. Urology
6.8.5. Diabetes
6.8.6. CNS
6.8.7. Others
6.9. Global Gene Delivery System Market Forecast, by Application
6.9.1. Infectious Diseases
6.9.2. Oncology
6.9.3. Ophthalmology
6.9.4. Urology
6.9.5. Diabetes
6.9.6. CNS
6.9.7. Others
6.10. Global Drug Delivery System Market Attractiveness, by Application
6.11. Global Gene Delivery System Market Attractiveness, by Application
Section 07 Global Drug and Gene Delivery Systems Market Analysis, by Route of Administration
7.1. Key Findings
7.2. Introduction & Definitions
7.3. Introduction: Drug Delivery Systems
7.4. Introduction: Gene Delivery Systems
7.5. Global Drug Delivery Systems Market, by Route of Administration
7.6. Global Gene Delivery Systems Market Value Share Analysis, by Route of Administration
7.7. Global Drug Delivery Systems Market Forecast, by Route of Administration
7.7.1. Oral
7.7.2. Injectable
7.7.3. Inhalation
7.7.4. Transdermal
7.7.5. Ocular
7.7.6. Nasal
7.7.7. Topical
7.8. Global Gene Delivery Systems Market Forecast, by Route of Administration
7.8.1. Oral
7.8.2. Injectable
7.8.3. Inhalation
7.8.4. Transdermal
7.8.5. Ocular
7.8.6. Nasal
7.8.7. Topical
7.9. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Drug Delivery: Route of Administration
7.10. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Gene Delivery: Route of Administration
Section 08 Global Drug and Gene Delivery Systems Market Analysis, by Region
8.1. Global Drug and Gene Delivery System Market Overview
8.2. Introduction
8.3. Global Drug and Gene Delivery System Market Value Share Analysis, by Region
8.4. Global Drug and Gene Delivery System Market Forecast, by Region
8.4.1. North America
8.4.2. Europe
8.4.3. Asia Pacific
8.4.4. Middle East & Africa
8.4.5. Latin America
8.5. Global Drug and Gene Delivery System Market Attractiveness Analysis, by Region
Section 09 North America Drug and Gene Delivery System Market Analysis
9.1. Key Findings
9.2. North America Drug and Gene Delivery System Market Overview
9.3. North America Drug and Gene Delivery System Market Overview, by Country
9.4. North America Drug and Gene Delivery System Market Value Share Analysis, by Country
9.5. North America Drug Delivery System Market Forecast, by Country
9.5.1. U.S.
9.5.2. Canada
9.6. North America Gene Delivery System Market Forecast, by Country
9.6.1. U.S.
9.6.2. Canada
9.7. North America Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
9.8. North America Drug and Gene Delivery System Market Forecast, by Drug Delivery System
9.8.1. Intrauterine Implants
9.8.2. Prodrug Implants
9.8.3. Polymeric Drug Delivery
9.8.4. Targeted Drug Delivery
9.9. North America Drug and Gene Delivery System Market Forecast, by Gene Delivery System
9.9.1. Viral Gene Delivery
9.9.2. Non-viral Gene Delivery
9.9.3. Combined Hybrid System
9.10. North America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
9.11. North America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
9.12. North America Gene Delivery System Market Forecast, by Viral Gene Delivery
9.12.1. Adenovirus Vector
9.12.2. Lentivirus Vector
9.12.3. Retrovirus Vector
9.12.4. Adeno-associated Virus Vector
9.12.5. Sendai Virus Vector
9.12.6. Herpes Simplex Virus Vector
9.12.7. Others
9.13. North America Gene Delivery System Market Forecast, by Non-viral Gene Delivery
9.13.1. Natural Organic Compounds
9.13.2. Physical Methods
9.13.3. Chemical Methods
9.14. North America Drug and Gene Delivery System Market Value Share Analysis, by Application
9.15. North America Drug Delivery System Market Forecast, by Application
9.15.1. Infectious Diseases
9.15.2. Oncology
9.15.3. Ophthalmology
9.15.4. Urology
9.15.5. Diabetes
9.15.6. CNS
9.15.7. Others
9.16. North America Gene Delivery System Market Forecast, by Application
9.16.1. Infectious Diseases
9.16.2. Oncology
9.16.3. Ophthalmology
9.16.4. Urology
9.16.5. Diabetes
9.16.6. CNS
9.16.7. Others
9.17. North America Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
9.18. North America Drug Delivery System Market Forecast, by Route of Administration
9.18.1. Oral
9.18.2. Injectable
9.18.3. Inhalation
9.18.4. Transdermal
9.18.5. Ocular
9.18.6. Nasal
9.18.7. Topical
9.19. North America Gene Delivery System Market Forecast, by Route of Administration
9.20. North America Drug and Gene Delivery System Market Attractiveness Analysis
Section 10 Europe Drug and Gene Delivery System Market Analysis
10.1. Key Findings
10.2. Europe Drug and Gene Delivery System Market Overview
10.3. Europe Drug and Gene Delivery System Market Overview, by Country/Sub-region
10.4. Europe Drug and Gene Delivery System Market Value Share Analysis, by Country/Sub-region
10.5. Europe Drug Delivery System Market Forecast, by Country/Sub-region
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Europe Gene Delivery System Market Forecast, by Country/Sub-region
10.6.1. Germany
10.6.2. U.K.
10.6.3. France
10.6.4. Italy
10.6.5. Spain
10.6.6. Rest of Europe
10.7. Europe Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
10.8. Europe Drug and Gene Delivery System Market Forecast, by Drug Delivery System
10.8.1. Intrauterine Implants
10.8.2. Prodrug Implants
10.8.3. Polymeric Drug Delivery
10.8.4. Targeted Drug Delivery
10.9. Europe Drug and Gene Delivery System Market Forecast, by Gene Delivery System
10.9.1. Viral Gene Delivery
10.9.2. Non-viral Gene Delivery
10.9.3. Combined Hybrid System
10.10. Europe Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
10.11. Europe Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
10.12. Europe Gene Delivery System Market Forecast, by Viral Gene Delivery
10.12.1. Adenovirus Vector
10.12.2. Lentivirus Vector
10.12.3. Retrovirus Vector
10.12.4. Adeno-associated Virus Vector
10.12.5. Sendai Virus Vector
10.12.6. Herpes Simplex Virus Vector
10.12.7. Others
10.13. Europe Gene Delivery System Market Forecast, by Non-viral Gene Delivery
10.13.1. Natural Organic Compounds
10.13.2. Physical Methods
10.13.3. Chemical Methods
10.14. Europe Drug and Gene Delivery System Market Value Share Analysis, by Application
10.15. Europe Drug Delivery System Market Forecast, by Application
10.15.1. Infectious Diseases
10.15.2. Oncology
10.15.3. Ophthalmology
10.15.4. Urology
10.15.5. Diabetes
10.15.6. CNS
10.15.7. Others
10.16. Europe Gene Delivery System Market Forecast, by Application
10.16.1. Infectious Diseases
10.16.2. Oncology
10.16.3. Ophthalmology
10.16.4. Urology
10.16.5. Diabetes
10.16.6. CNS
10.16.7. Others
10.17. Europe Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
10.18. Europe Drug Delivery System Market Forecast, by Route of Administration
10.18.1. Oral
10.18.2. Injectable
10.18.3. Inhalation
10.18.4. Transdermal
10.18.5. Ocular
10.18.6. Nasal
10.18.7. Topical
10.19. Europe Gene Delivery System Market Forecast, by Route of Administration
10.20. Europe Drug and Gene Delivery System Market Attractiveness Analysis
Section 11 Asia Pacific Drug and Gene Delivery System Market Analysis
11.1. Key Findings
11.2. Asia Pacific Drug and Gene Delivery System Market Overview
11.3. Asia Pacific Drug and Gene Delivery System Market Overview, by Country/Sub-region
11.4. Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Country/Sub-region
11.5. Asia Pacific Drug Delivery System Market Forecast, by Country/Sub-region
11.5.1. Japan
11.5.2. China
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Asia Pacific Drug Delivery System Market Forecast, by Country/Sub-region
11.6.1. Japan
11.6.2. China
11.6.2. India
11.6.4. Australia & New Zealand
11.6.5. Rest of Asia Pacific
11.7. Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
11.8. Asia Pacific Drug and Gene Delivery System Market Forecast, by Drug Delivery System
11.8.1. Intrauterine Implants
11.8.2. Prodrug Implants
11.8.3. Polymeric Drug Delivery
11.8.4. Targeted Drug Delivery
11.9. Asia Pacific Drug and Gene Delivery System Market Forecast, by Gene Delivery System
11.9.1. Viral Gene Delivery
11.9.2. Non-viral Gene Delivery
11.9.3. Combined Hybrid System
11.10. Asia Pacific Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
11.11. Asia Pacific Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
11.12. Asia Pacific Gene Delivery System Market Forecast, by Viral Gene Delivery
11.12.1. Adenovirus Vector
11.12.2. Lentivirus Vector
11.12.3. Retrovirus Vector
11.12.4. Adeno-associated Virus Vector
11.12.5. Sendai Virus Vector
11.12.6. Herpes Simplex Virus Vector
11.12.7. Others
11.13. Asia Pacific Gene Delivery System Market Forecast, by Non-viral Gene Delivery
11.13.1. Natural Organic Compounds
11.13.2. Physical Methods
11.13.3. Chemical Methods
11.14. Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Application
11.15. Asia Pacific Drug Delivery System Market Forecast, by Application
11.15.1. Infectious Diseases
11.15.2. Oncology
11.15.3. Ophthalmology
11.15.4. Urology
11.15.5. Diabetes
11.15.6. CNS
11.15.7. Others
11.16. Asia Pacific Gene Delivery System Market Forecast, by Application
11.16.1. Infectious Diseases
11.16.2. Oncology
11.16.3. Ophthalmology
11.16.4. Urology
11.16.5. Diabetes
11.16.6. CNS
11.16.7. Others
11.17. Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
11.18. Asia Pacific Drug Delivery System Market Forecast, by Route of Administration
11.18.1. Oral
11.18.2. Injectable
11.18.3. Inhalation
11.18.4. Transdermal
11.18.5. Ocular
11.18.6. Nasal
11.18.7. Topical
11.19. Asia Pacific Gene Delivery System Market Forecast, by Route of Administration
11.20. Asia Pacific Drug and Gene Delivery System Market Attractiveness Analysis
Section 12 Latin America Drug and Gene Delivery System Market Analysis
12.1. Key Findings
12.2. Latin America Drug and Gene Delivery System Market Overview
12.3. Latin America Drug and Gene Delivery System Market Overview, by Country/Sub-region
12.4. Latin America Drug and Gene Delivery System Market Value Share Analysis, by Country/Sub-region
12.5. Latin America Drug Delivery System Market Forecast, by Country/Sub-region
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Latin America Gene Delivery System Market Forecast, by Country/Sub-region
12.6.1. Brazil
12.6.2. Mexico
12.6.3. Rest of Latin America
12.7. Latin America Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
12.8. Latin America Drug and Gene Delivery System Market Forecast, by Drug Delivery System
12.8.1. Intrauterine Implants
12.8.2. Prodrug Implants
12.8.3. Polymeric Drug Delivery
12.8.4. Targeted Drug Delivery
12.9. Latin America Drug and Gene Delivery System Market Forecast, by Gene Delivery System
12.9.1. Viral Gene Delivery
12.9.2. Non-viral Gene Delivery
12.9.3. Combined Hybrid System
12.10. Latin America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
12.11. Latin America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
12.12. Latin America Gene Delivery System Market Forecast, by Viral Gene Delivery
12.12.1. Adenovirus Vector
12.12.2. Lentivirus Vector
12.12.3. Retrovirus Vector
12.12.4. Adeno-associated Virus Vector
12.12.5. Sendai Virus Vector
12.12.6. Herpes Simplex Virus Vector
12.12.7. Others
12.13. Latin America Gene Delivery System Market Forecast, by Non-viral Gene Delivery
12.13.1. Natural Organic Compounds
12.13.2. Physical Methods
12.13.3. Chemical Methods
12.14. Latin America Drug and Gene Delivery System Market Value Share Analysis, by Application
12.15. Latin America Drug Delivery System Market Forecast, by Application
12.15.1. Infectious Diseases
12.15.2. Oncology
12.15.3. Ophthalmology
12.15.4. Urology
12.15.5. Diabetes
12.15.6. CNS
12.15.7. Others
12.16. Latin America Gene Delivery System Market Forecast, by Application
12.16.1. Infectious Diseases
12.16.2. Oncology
12.16.3. Ophthalmology
12.16.4. Urology
12.16.5. Diabetes
12.16.6. CNS
12.16.7. Others
12.17. Latin America Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
12.18. Latin America Drug Delivery System Market Forecast, by Route of Administration
12.18.1. Oral
12.18.2. Injectable
12.18.3. Inhalation
12.18.4. Transdermal
12.18.5. Ocular
12.18.6. Nasal
12.18.7. Topical
12.19. Latin America Gene Delivery System Market Forecast, by Route of Administration
12.20. Latin America Drug and Gene Delivery System Market Attractiveness Analysis
Section 13 Middle East & Africa Drug and Gene Delivery System Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Drug and Gene Delivery System Market Overview
13.3. Middle East & Africa Drug and Gene Delivery System Market Overview, by Country/Sub-region
13.4. Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Country/Sub-region
13.5. Middle East & Africa Drug Delivery System Market Forecast, by Country/Sub-region
13.5.1. GCC
13.5.2. South Africa
13.5.3. Israel
13.5.4. Rest of MEA
13.6. Middle East & Africa Drug Delivery System Market Forecast, by Country/Sub-region
13.6.1. GCC
13.6.2. South Africa
13.6.3. Israel
13.6.4. Rest of MEA
13.7. Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
13.8. Middle East & Africa Drug and Gene Delivery System Market Forecast, by Drug Delivery System
13.8.1. Intrauterine Implants
13.8.2. Prodrug Implants
13.8.3. Polymeric Drug Delivery
13.8.4. Targeted Drug Delivery
13.9. Middle East & Africa Drug and Gene Delivery System Market Forecast, by Gene Delivery System
13.9.1. Viral Gene Delivery
13.9.2. Non-viral Gene Delivery
13.9.3. Combined Hybrid System
13.10. Latin America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
13.11. Middle East & Africa Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
13.12. Middle East & Africa Gene Delivery System Market Forecast, by Viral Gene Delivery
13.12.1. Adenovirus Vector
13.12.2. Lentivirus Vector
13.12.3. Retrovirus Vector
13.12.4. Adeno-associated Virus Vector
13.12.5. Sendai Virus Vector
13.12.6. Herpes Simplex Virus Vector
13.12.7. Others
13.13. Middle East & Africa Gene Delivery System Market Forecast, by Non-viral Gene Delivery
13.13.1. Natural Organic Compounds
13.13.2. Physical Methods
13.13.3. Chemical Methods
13.14. Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Application
13.15. Middle East & Africa Drug Delivery System Market Forecast, by Application
13.15.1. Infectious Diseases
13.15.2. Oncology
13.15.3. Ophthalmology
13.15.4. Urology
13.15.5. Diabetes
13.15.6. CNS
13.15.7. Others
13.16. Middle East & Africa Gene Delivery System Market Forecast, by Application
13.16.1. Infectious Diseases
13.16.2. Oncology
13.16.3. Ophthalmology
13.16.4. Urology
13.16.5. Diabetes
13.16.6. CNS
13.16.7. Others
13.17. Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
13.18. Middle East & Africa Drug Delivery System Market Forecast, by Route of Administration
13.18.1. Oral
13.18.2. Injectable
13.18.3. Inhalation
13.18.4. Transdermal
13.18.5. Ocular
13.18.6. Nasal
13.18.7. Topical
13.19. Middle East & Africa Gene Delivery System Market Forecast, by Route of Administration
13.20. Middle East & Africa Drug and Gene Delivery System Market Attractiveness Analysis
Section 14 Competition Landscape
14.1. Competition Matrix
Section 15 Company Profiles
15.1. Novartis AG
15.1.1. Company Description
15.1.2. Financial Overview
15.1.3. Strategy & Recent Developments
15.1.4. SWOT Analysis
15.2. Amgen Inc.
15.2.1. Company Description
15.2.2. Financial Overview
15.2.3. Strategy & Recent Developments
15.2.4. SWOT Analysis
15.3. Oxford BioMedica plc.
15.3.1. Company Description
15.3.2. Financial Overview
15.3.3. Strategy & Recent Developments
15.3.4. SWOT Analysis
15.4. SIBIONO
15.4.1. Company Description
15.4.2. Financial Overview
15.4.3. Strategy & Recent Developments
15.4.4. SWOT Analysis
15.5. Shanghai Sunway Biotech Co., Ltd.
15.5.1. Company Description
15.5.2. Financial Overview
15.5.3. Strategy & Recent Developments
15.5.4. SWOT Analysis
15.6. F. Hoffmann-La Roche Ltd.
15.6.1. Company Description
15.6.2. Financial Overview
15.6.3. Strategy & Recent Developments
15.6.4. SWOT Analysis
15.7. Pfizer, Inc.
15.7.1. Company Description
15.7.2. Financial Overview
15.7.3. Strategy & Recent Developments
15.7.4. SWOT Analysis
15.8. Bayer AG
15.8.1. Company Description
15.8.2. Financial Overview
15.8.3. Strategy & Recent Developments
15.8.4. SWOT Analysis
15.9. Johnson & Johnson Services, Inc.
15.9.1. Company Description
15.9.2. Financial Overview
15.9.3. Strategy & Recent Developments
15.9.4. SWOT Analysis
15.10. Becton, Dickinson and Company
15.10.1. Company Description
15.10.2. Financial Overview
15.10.3. Strategy & Recent Developments
15.10.4. SWOT Analysis
15.11. AstraZeneca plc.
15.11.1. Company Description
15.11.2. Financial Overview
15.11.3. Strategy & Recent Developments
15.11.4. SWOT Analysis
15.12. Baxter International, Inc.
15.12.1. Company Description
15.12.2. Financial Overview
15.12.3. Strategy & Recent Developments
15.12.4. SWOT Analysis
15.13. Human Stem Cells Institute
15.13.1. Company Description
15.13.2. Financial Overview
15.13.3. Strategy & Recent Developments
15.13.4. SWOT Analysis
15.14. Boston Scientific Corporation
15.14.1. Company Description
15.14.2. Financial Overview
15.14.3. Strategy & Recent Developments
15.14.4. SWOT Analysis
15.15. Epeius Biotechnologies Corporation
15.15.1. Company Description
15.15.2. Financial Overview
15.15.3. Strategy & Recent Developments
15.15.4. SWOT Analysis
List of Tables
Table 01: Regulatory Scenario in Different Countries
Table 02: Gene Therapy Pipeline Molecules
Table 03: Drug Therapy Pipeline Products
Table 04: Global Drug and Gene Delivery Systems Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
Table 05: Global Drug and Gene Delivery Systems Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
Table 06: Global Drug and Gene Delivery Systems Market Size (US$ Mn) Forecast, by Gene Delivery System: Viral Gene Delivery, 2015–2025
Table 07: Global Drug and Gene Delivery Systems Market Size (US$ Mn) Forecast, by Gene Delivery System: Non-viral Gene Delivery, 2015–2025
Table 08: Global Drug Delivery System Market Value (US$ Bn) Forecast, by Application, 2015–2025
Table 09: Global Gene Delivery System Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 10: Global Drug and Gene Delivery Systems Market Value (US$ Bn) Forecast, by Drug Delivery: Route of Administration, 2015–2025
Table 11: Global Drug and Gene Delivery Systems Market Value (US$ Mn) Forecast, by Gene Delivery: Route of Administration, 2015–2025
Table 12: Global Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Region, 2015–2025
Table 13: North America Drug Delivery System Market Size (US$ Bn) Forecast, by Country, 2015–2025
Table 14: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 15: North America Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
Table 16: North America Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
Table 17: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 18: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 19: North America Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 20: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 21: North America Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 22: North America Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 23: Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 24: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 25: Europe Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
Table 26: Europe Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
Table 27: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 28: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 29: Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 30: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 31: Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 32: Europe Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 33: Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 34: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 35: Asia Pacific Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
Table 36: Asia Pacific Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
Table 37: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 38: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 39: Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 40: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 41: Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 42: Asia Pacific Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 43: Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 44: Latin America Gene Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 45: Latin America Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
Table 46: Latin America Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
Table 47: Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 48: Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 49: Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 50: Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 51: Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 52: Latin America Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 53: Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 54: Middle East & Africa Gene Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 55: Middle East & Africa Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
Table 56: Middle East & Africa Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
Table 57: Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025, 2015–2025
Table 58: Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 59: Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 60: Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 61: Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 62: Middle East & Africa Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
List of Figures
Figure 01: Global Drug and Gene Delivery System Market Snapshot
Figure 02: Global Drug and Gene Delivery System Market Size (US$ Bn), by Route of Administration, 2016
Figure 03: Global Drug and Gene Delivery System Market Size (US$ Mn), by Region, 2016 and 2025
Figure 04: Global Drug and Gene Delivery System Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 05: Global Drug and Gene Delivery System Market Value Share, by Type of Gene Delivery System (2016)
Figure 06: Global Drug Delivery System Market Value Share, by Type of Drug Delivery System (2016)
Figure 07: Global Drug and Gene Delivery System Market Value Share, by Application (2016)
Figure 08: Global Drug and Gene Delivery Systems Market Value Share, by Drug Delivery System, 2016 and 2025
Figure 09: Global Drug and Gene Delivery Systems Market Value Share, by Gene Delivery System, 2016 and 2025
Figure 10: Global Drug and Gene Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Drug Delivery System: Intrauterine Implants, 2015–2025
Figure 11: Global Drug and Gene Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Drug Delivery System: Prodrug Implants, 2015–2025
Figure 12: Global Drug and Gene Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Drug Delivery System: Polymeric Drug Delivery, 2015–2025
Figure 13: Global Drug and Gene Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Drug Delivery System: Targeted Drug Delivery, 2015–2025
Figure 14: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gene Delivery System: Viral Gene Delivery, 2015–2025
Figure 15: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gene Delivery System: Non-viral Gene Delivery, 2015–2025
Figure 16: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gene Delivery System: Combined Hybrid Systems, 2015–2025
Figure 17: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Adenovirus Vector, 2015–2025
Figure 18: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Lentivirus Vector, 2015–2025
Figure 19: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Retrovirus Vector, 2015–2025
Figure 20: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Adeno-associated Virus Vector, 2015–2025
Figure 21: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Sendai Virus Vector, 2015–2025
Figure 22: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Herpes Simplex Virus Vector, 2015–2025
Figure 23: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Others, 2015–2025
Figure 24: Global Drug and Gene Delivery Systems Market Attractiveness, by Drug Delivery System, 2017–2025
Figure 25: Global Drug and Gene Delivery Systems Market Attractiveness, by Gene Delivery System, 2017–2025
Figure 26: Global Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 27: Global Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 28: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Infectious Diseases, 2015–2025
Figure 29: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Oncology, 2015–2025
Figure 30: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Ophthalmology, 2015–2025
Figure 31: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Urology, 2015–2025
Figure 32: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Diabetes, 2015–2025
Figure 33: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by CNS, 2015–2025
Figure 34: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 35: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Infectious Diseases, 2015–2025
Figure 36: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oncology, 2015–2025
Figure 37: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ophthalmology, 2015–2025
Figure 38: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urology, 2015–2025
Figure 39: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes, 2015–2025
Figure 40: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CNS, 2015–2025
Figure 41: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 42: Global Drug Delivery System Market Attractiveness, by Application, 2017–2025
Figure 43: Global Gene Delivery System Market Attractiveness, by Application, 2017–2025
Figure 44: Global Drug and Gene Delivery Systems Market Value Share, by Drug Delivery: Route of Administration, 2016 and 2025
Figure 45: Global Gene Delivery Systems Market Value Share, by Route of Administration, 2016 and 2025
Figure 46: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2015–2025
Figure 47: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Injectable, 2015–2025
Figure 48: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Inhalation, 2015–2025
Figure 49: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Transdermal, 2015–2025
Figure 50: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Ocular, 2015–2025
Figure 51: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Nasal, 2015–2025
Figure 52: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2015–2025
Figure 53: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2015–2025
Figure 54: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Injectable, 2015–2025
Figure 55: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Inhalation, 2015–2025
Figure 56: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Transdermal, 2015–2025
Figure 57: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ocular, 2015–2025
Figure 58: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Nasal, 2015–2025
Figure 59: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2015–2025
Figure 60: Global Drug and Gene Delivery Systems Market Attractiveness, by Drug Delivery: Route of Administration, 2017–2025
Figure 61: Global Drug and Gene Delivery Systems Market Attractiveness, by Gene Delivery: Route of Administration, 2017–2025
Figure 62: Global Drug and Gene Delivery System Market Revenue (US$ Bn) Forecast, 2015–2025
Figure 63: Global Drug and Gene Delivery System Market Value Share Analysis, by Region, 2016 and 2025
Figure 64: Global Drug and Gene Delivery System Market Attractiveness, by Region, 2017–2025
Figure 65: North America Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 66: North America Drug Delivery System Market Attractiveness Analysis, by Country, 2017–2025
Figure 67: North America Gene Delivery System Market Attractiveness Analysis, by Country, 2017–2025
Figure 68: North America Drug Delivery System Market Value Share Analysis, by Country, 2016 and 2025
Figure 69: North America Gene Delivery System Market Value Share Analysis, by Country, 2016 and 2025
Figure 70: North America Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
Figure 71: North America Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
Figure 72: North America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
Figure 73: North America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
Figure 74: North America Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 75: North America Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 76: North America Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 77: North America Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 78: North America Drug and Gene Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 79: North America Drug and Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 80: Europe Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 81: Europe Drug Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 82: Europe Gene Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 83: Europe Drug Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 84: Europe Gene Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 85: Europe Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
Figure 86: Europe Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
Figure 87: Europe Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
Figure 88: Europe Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
Figure 89: Europe Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 90: Europe Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 91: Europe Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 92: Europe Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 93: Europe Drug Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 94: Europe Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 95: Asia Pacific Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 96: Asia Pacific Drug Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 97: Asia Pacific Gene Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 98: Asia Pacific Drug Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 99: Asia Pacific Gene Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 100: Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
Figure 101: Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
Figure 102: Asia Pacific Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
Figure 103: Asia Pacific Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
Figure 104: Asia Pacific Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 105: Asia Pacific Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 106: Asia Pacific Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 107: Asia Pacific Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 108: Asia Pacific Drug Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 109: Asia Pacific Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 110: Latin America Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 111: Latin America Drug Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 112: Latin America Gene Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 113: Latin America Drug Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 114: Latin America Gene Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 115: Latin America Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
Figure 116: Latin America Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
Figure 117: Latin America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
Figure 118: Latin America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
Figure 119: Latin America Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 120: Latin America Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 121: Latin America Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 122: Latin America Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 123: Latin America Drug and Gene Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 124: Latin America Drug and Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 125: Middle East & Africa Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 126: Middle East & Africa Drug Delivery System Market Attractiveness Analysis, by Country/Sub-Region, 2017–2025
Figure 127: Middle East & Africa Gene Delivery System Market Attractiveness Analysis, by Country/Sub-Region, 2017–2025
Figure 128: Middle East & Africa Drug Delivery System Market Value Share Analysis, by Country/Sub-Region, 2016 and 2025
Figure 129: Middle East & Africa Gene Delivery System Market Value Share Analysis, by Country/Sub-Region, 2016 and 2025
Figure 130: Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
Figure 131: Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
Figure 132: Middle East & Africa Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
Figure 133: Middle East & Africa Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
Figure 134: Middle East & Africa Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 135: Middle East & Africa Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 136: Middle East & Africa Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 137: Middle East & Africa Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 138: Middle East & Africa Drug and Gene Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 139: Middle East & Africa Drug and Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Complete the form below and we'll get back to you shortly.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
